| Schedule of Fair Value Hierarchy of Financial Assets and Liabilities under U.S. GAAP Guidance |
The following tables set forth by level within the fair value hierarchy financial assets and liabilities accounted for at fair value under U.S. GAAP guidance (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets at Fair Value at March 31, 2026 | | Level 1 | | Level 2 | | Level 3 | | Netting and Collateral | | Total | | Financial instruments owned, at fair value—Domestic government debt | $ | 71,259 | | | $ | — | | | $ | — | | | $ | — | | | $ | 71,259 | | | Financial instruments owned, at fair value—Foreign government debt | — | | | 25,477 | | | — | | | — | | | 25,477 | | | Financial instruments owned, at fair value—Equities | 670 | | | — | | | — | | | — | | | 670 | | | | | | | | | | | | | FX swaps | — | | | 4,486 | | | — | | | (508) | | | 3,978 | | | Interest rate swaps | — | | | 17,779 | | | — | | | (16,103) | | | 1,676 | | | Forwards | — | | | 273 | | | — | | | (26) | | | 247 | | | Futures | 104,345 | | | — | | | — | | | (104,345) | | | — | | | Total | $ | 176,274 | | | $ | 48,015 | | | $ | — | | | $ | (120,982) | | | $ | 103,307 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities at Fair Value at March 31, 2026 | | Level 1 | | Level 2 | | Level 3 | | Netting and Collateral | | Total | | FX swaps | $ | — | | | $ | 3,972 | | | $ | — | | | $ | (508) | | | $ | 3,464 | | | Futures | 105,365 | | | — | | | — | | | (104,345) | | | 1,020 | | | Forwards | — | | | 728 | | | — | | | (26) | | | 702 | | | Interest rate swaps | — | | | 16,103 | | | — | | | (16,103) | | | — | | | Contingent consideration | — | | | — | | | 18,414 | | | — | | | 18,414 | | | Total | $ | 105,365 | | | $ | 20,803 | | | $ | 18,414 | | | $ | (120,982) | | | $ | 23,600 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets at Fair Value at December 31, 2025 | | Level 1 | | Level 2 | | Level 3 | | Netting and Collateral | | Total | | Financial instruments owned, at fair value—Domestic government debt | $ | 97,546 | | | $ | — | | | $ | — | | | $ | — | | | $ | 97,546 | | | Financial instruments owned, at fair value—Foreign government debt | — | | | 29,054 | | | — | | | — | | | 29,054 | | | Financial instruments owned, at fair value—Equities | 955 | | | — | | | — | | | — | | | 955 | | | Financial instruments owned, at fair value—Corporate bonds | — | | | 59 | | | — | | | — | | | 59 | | | FX swaps | — | | | 2,424 | | | — | | | (651) | | | 1,773 | | | Forwards | — | | | 929 | | | — | | | (274) | | | 655 | | | Futures | 44,469 | | | — | | | — | | | (44,469) | | | — | | | | | | | | | | | | | Total | $ | 142,970 | | | $ | 32,466 | | | $ | — | | | $ | (45,394) | | | $ | 130,042 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities at Fair Value at December 31, 2025 | | Level 1 | | Level 2 | | Level 3 | | Netting and Collateral | | Total | | FX swaps | $ | — | | | $ | 1,673 | | | $ | — | | | $ | (651) | | | $ | 1,022 | | | Forwards | — | | | 658 | | | — | | | (274) | | | 384 | | | Futures | 44,671 | | | — | | | — | | | (44,469) | | | 202 | | | | | | | | | | | | | Contingent consideration | — | | | — | | | 22,662 | | | — | | | 22,662 | | | Total | $ | 44,671 | | | $ | 2,331 | | | $ | 22,662 | | | $ | (45,394) | | | $ | 24,270 | |
|
| Schedule of Changes in Level 3 Financial Liabilities Measured at Fair Value on Recurring Basis |
Changes in Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2026 were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealized gains (losses) for the period included in: | | Opening Balance at January 1, 2026 | | Total realized and unrealized (gains) losses included in Net income (loss)¹ | | | | Sales/ Settlements | | Closing Balance at March 31, 2026 | | Net (income) loss on Level 3 Assets/Liabilities Outstanding at March 31, 2026 | | Other comprehensive income (loss) on Level 3 Assets/Liabilities Outstanding at March 31, 2026 | | Liabilities | | | | | | | | | | | | | | | Accounts payable, accrued and other liabilities: | | | | | | | | | | | | | | | Contingent consideration | $ | 22,662 | | | $ | 1,169 | | | | | $ | (5,417) | | | $ | 18,414 | | | $ | 1,203 | | | $ | — | |
____________________________ 1Realized and unrealized gains (losses) are reported in “Other income (loss)” in the Company’s unaudited Condensed Consolidated Statements of Operations. Changes in Level 3 liabilities measured at fair value on a recurring basis for the three months ended March 31, 2025 were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Unrealized gains (losses) for the period included in: | | Opening Balance at January 1, 2025 | | Total realized and unrealized (gains) losses included in Net income (loss)¹ | | | | | | Sales/ Settlements | | Closing Balance at March 31, 2025 | | Net (income) loss on Level 3 Assets/Liabilities Outstanding at March 31, 2025 | | Other comprehensive income (loss) on Level 3 Assets/Liabilities Outstanding at March 31, 2025 | | Liabilities | | | | | | | | | | | | | | | | | Accounts payable, accrued and other liabilities: | | | | | | | | | | | | | | | | | Contingent consideration | $ | 21,768 | | | $ | 1,423 | | | | | | | $ | (1,523) | | | $ | 21,668 | | | $ | 1,423 | | | $ | — | |
____________________________ 1Realized and unrealized gains (losses) are reported in “Other income (loss)” in the Company’s unaudited Condensed Consolidated Statements of Operations.
|
| Schedule of Quantitative Information about Level 3 Fair Value Measurements on Recurring Basis |
The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurement of Level 3 liabilities measured at fair value on a recurring basis (dollar amounts in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value as of March 31, 2026 | | | | | | | | | | Assets | | Liabilities | | Valuation Technique | | Unobservable Inputs | | Range | | Weighted Average | | | | | | | | Discount rate1 | | 7.5%-7.5% | | 7.5% | | | | | | | | | | | | | | Contingent consideration | $ | — | | | $ | 18,414 | | | Present value of expected payments | | Probability of meeting earnout and contingencies | | 70%-100% | | 86.2%2 |
____________________________ 1The discount rate is based on the Company’s calculated weighted-average cost of capital. 2The probability of meeting the earnout targets was based on the acquirees’ projected future financial performance, including revenues. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value as of December 31, 2025 | | | | | | | | | | Assets | | Liabilities | | Valuation Technique | | Unobservable Inputs | | Range | | Weighted Average | | | | | | | | Discount rate1 | | 7.5%-9.2% | | 7.5% | | | | | | | | | | | | | | Contingent consideration | $ | — | | | $ | 22,662 | | | Present value of expected payments | | Probability of meeting earnout and contingencies | | 50%-100% | | 85.0%2 |
____________________________ 1The discount rate is based on the Company’s calculated weighted-average cost of capital. 2The probability of meeting the earnout targets was based on the acquirees’ projected future financial performance, including revenues.
|